NDC 33342-085

Olanzapine

Olanzapine

Olanzapine is a Oral Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is Olanzapine.

Product ID33342-085_4691060f-2ad1-4b4d-a8c0-498ce0b768d3
NDC33342-085
Product TypeHuman Prescription Drug
Proprietary NameOlanzapine
Generic NameOlanzapine
Dosage FormTablet, Orally Disintegrating
Route of AdministrationORAL
Marketing Start Date2015-02-27
Marketing CategoryANDA / ANDA
Application NumberANDA203044
Labeler NameMacleods Pharmaceuticals Limited
Substance NameOLANZAPINE
Active Ingredient Strength15 mg/1
Pharm ClassesAtypical Antipsychotic [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 33342-085-07

30 TABLET, ORALLY DISINTEGRATING in 1 CONTAINER (33342-085-07)
Marketing Start Date2015-02-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 33342-085-07 [33342008507]

Olanzapine TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA203044
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-02-27

NDC 33342-085-12 [33342008512]

Olanzapine TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA203044
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-27

NDC 33342-085-11 [33342008511]

Olanzapine TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA203044
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-02-27

NDC 33342-085-15 [33342008515]

Olanzapine TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA203044
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-27

Drug Details

Active Ingredients

IngredientStrength
OLANZAPINE15 mg/1

OpenFDA Data

SPL SET ID:df43938a-3469-40eb-8166-f0a2fd29d6d8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 351108
  • 351107
  • 314155
  • 312076
  • Pharmacological Class

    • Atypical Antipsychotic [EPC]

    Medicade Reported Pricing

    33342008511 OLANZAPINE ODT 15 MG TABLET

    Pricing Unit: EA | Drug Type:

    33342008507 OLANZAPINE ODT 15 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Olanzapine" or generic name "Olanzapine"

    NDCBrand NameGeneric Name
    67877-175OlanzapineOlanzapine
    67877-174OlanzapineOlanzapine
    67877-172OlanzapineOlanzapine
    67877-173OlanzapineOlanzapine
    67877-176OlanzapineOlanzapine
    67877-177OlanzapineOlanzapine
    68084-529OlanzapineOlanzapine
    68084-723OlanzapineOlanzapine
    68084-528OlanzapineOlanzapine
    68084-740OlanzapineOlanzapine
    68084-525OlanzapineOlanzapine
    68258-7095OlanzapineOlanzapine
    68258-7152OlanzapineOlanzapine
    68258-7153OlanzapineOlanzapine
    68258-7154OlanzapineOlanzapine
    68382-365olanzapineolanzapine
    68382-368olanzapineolanzapine
    68258-7096OlanzapineOlanzapine
    68382-367olanzapineolanzapine
    68382-364olanzapineolanzapine
    68382-366olanzapineolanzapine
    68382-369olanzapineolanzapine
    68788-7161OlanzapineOlanzapine
    0517-0955OlanzapineOlanzapine
    69189-5510OlanzapineOlanzapine
    69543-384OlanzapineOlanzapine
    69543-380OlanzapineOlanzapine
    69543-381OlanzapineOlanzapine
    69543-383OlanzapineOlanzapine
    69543-382OlanzapineOlanzapine
    69543-385OlanzapineOlanzapine
    69807-2012OlanzapineOlanzapine
    69807-2011OlanzapineOlanzapine
    69807-2013OlanzapineOlanzapine
    70518-0026OlanzapineOlanzapine
    70518-0148OlanzapineOlanzapine
    70518-0145OlanzapineOlanzapine
    70518-0149OlanzapineOlanzapine
    70518-0314OlanzapineOlanzapine
    70518-0477OlanzapineOlanzapine
    70518-0110OlanzapineOlanzapine
    70518-0616OlanzapineOlanzapine
    70518-0144OlanzapineOlanzapine
    70518-0433OlanzapineOlanzapine
    70518-1206OlanzapineOlanzapine
    70518-0921OlanzapineOlanzapine
    70518-1207OlanzapineOlanzapine
    70518-0615OlanzapineOlanzapine
    70518-1115OlanzapineOlanzapine
    70518-1154OlanzapineOlanzapine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.